BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1809814)

  • 21. Changing perspectives of H2 antagonists for stress ulcer prophylaxis.
    Bezarro ER
    Crit Care Nurs Clin North Am; 1993 Jun; 5(2):325-31. PubMed ID: 8104424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevention of stress ulcer with topically active drugs: an effective and sensible therapeutic approach? Arguments pro].
    Gugler R
    Z Gastroenterol; 1991 Jan; 29 Suppl 1():16-8; discussion 21-2. PubMed ID: 1683733
    [No Abstract]   [Full Text] [Related]  

  • 23. Optimal therapy for stress gastritis.
    Maier RV; Mitchell D; Gentilello L
    Ann Surg; 1994 Sep; 220(3):353-60; discussion 360-3. PubMed ID: 8092901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevention of stress ulcer with topically acting drugs: an effective and sensible therapeutic approach? Arguments contra].
    Janisch HD
    Z Gastroenterol; 1991 Jan; 29 Suppl 1():19-20; discussion 21-2. PubMed ID: 1962496
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma aluminum concentrations in long-term mechanically ventilated patients receiving stress ulcer prophylaxis with sucralfate.
    Tryba M; Kurz-Müller K; Donner B
    Crit Care Med; 1994 Nov; 22(11):1769-73. PubMed ID: 7956280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of nosocomial pneumonia in intubated patients: respective role of mechanical subglottic secretions drainage and stress ulcer prophylaxis.
    Mahul P; Auboyer C; Jospe R; Ros A; Guerin C; el Khouri Z; Galliez M; Dumont A; Gaudin O
    Intensive Care Med; 1992; 18(1):20-5. PubMed ID: 1578042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylaxis of stress ulcer bleeding. A meta-analysis.
    Tryba M
    J Clin Gastroenterol; 1991; 13 Suppl 2():S44-55. PubMed ID: 1832181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevention of stress hemorrhage in an internal medicine intensive care station: sucralfate versus ranitidine].
    Laggner AN; Lenz K; Graninger W; Gremmel F; Grimm G; Base W; Schneeweiss B; Sertl K
    Anaesthesist; 1988 Nov; 37(11):704-10. PubMed ID: 3063134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ventilator-associated pneumonia and upper airway colonisation with Gram negative bacilli: the role of stress ulcer prophylaxis in children.
    Lopriore E; Markhorst DG; Gemke RJ
    Intensive Care Med; 2002 Jun; 28(6):763-7. PubMed ID: 12107684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nosocomial pneumonia in ventilated trauma patients during stress ulcer prophylaxis with sucralfate, antacid, and ranitidine.
    Thomason MH; Payseur ES; Hakenewerth AM; Norton HJ; Mehta B; Reeves TR; Moore-Swartz MW; Robbins PI
    J Trauma; 1996 Sep; 41(3):503-8. PubMed ID: 8810971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Market research study of stress ulcer prevention].
    Bestehorn M
    Z Gastroenterol; 1991 Jan; 29 Suppl 1():45-51. PubMed ID: 1962501
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison of the frequency of stress ulceration and secondary pneumonia in sucralfate- or ranitidine-treated intensive care unit patients.
    Eddleston JM; Vohra A; Scott P; Tooth JA; Pearson RC; McCloy RF; Morton AK; Doran BH
    Crit Care Med; 1991 Dec; 19(12):1491-6. PubMed ID: 1959368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevention of acquired pneumonia during artificial ventilation (excluding the use of anti-infectious agents)].
    Fagon JY; Novara A; Stephan F; Girou E; Tournier B
    Rev Mal Respir; 1997 Jan; 14(1):13-9. PubMed ID: 9082501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of sucralfate vs antacids on gastric pathogens: results of a double-blind clinical trial.
    Ephgrave KS; Kleiman-Wexler R; Pfaller M; Booth BM; Reed D; Werkmeister L; Young S
    Arch Surg; 1998 Mar; 133(3):251-7. PubMed ID: 9517735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stress ulcer prophylaxis and ventilation pneumonia: prevention by antibacterial cytoprotective agents?
    Daschner F; Kappstein I; Engels I; Reuschenbach K; Pfisterer J; Krieg N; Vogel W
    Infect Control Hosp Epidemiol; 1988 Feb; 9(2):59-65. PubMed ID: 3343501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology, monitoring, and management of the ventilator-dependent patient: considerations for drug therapy, emphasis on stress ulcer prophylaxis.
    Dellinger RP
    DICP; 1990 Nov; 24(11 Suppl):S8-11. PubMed ID: 1980184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention of stress ulcer in intensive care patients].
    Laggner AN; Lenz K
    Wien Med Wochenschr; 1986 Nov; 136(21-22):596-9. PubMed ID: 2881401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective endoscopic study of stress erosions and ulcers in critically ill adult patients treated with either sucralfate or placebo.
    Eddleston JM; Pearson RC; Holland J; Tooth JA; Vohra A; Doran BH
    Crit Care Med; 1994 Dec; 22(12):1949-54. PubMed ID: 7988131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nosocomial pneumonia and the role of gastric pH. A meta-analysis.
    Cook DJ; Laine LA; Guyatt GH; Raffin TA
    Chest; 1991 Jul; 100(1):7-13. PubMed ID: 1676361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prophylaxis of stress ulcers].
    Kivilaakso E
    Duodecim; 1993; 109(3):237-42. PubMed ID: 7912180
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.